PolyPid Ltd. (PYPD)
NASDAQ·Healthcare·Biotechnology
$4.48
-2.18%
Mkt Cap $42.60M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$9.50
Range $9.00 – $10.00
Implied Upside
+112.1%
Consensus $9.50 vs current $4.48
NASDAQ·Healthcare·Biotechnology
$4.48
-2.18%
Mkt Cap $42.60M
No recent rating data.
Price Target (2 analysts)
$9.50
Range $9.00 – $10.00
+112.1%
Consensus $9.50 vs current $4.48